GLP-1 receptor agonists, such as Semaglutide, are FDA-approved prescription medications that play a crucial role in regulating food intake, controlling blood sugar levels, and enhancing feelings of fullness
Retatrutide seems to help with more weight loss than semaglutide
That distinguishes it sharply from tirzepatide, and it means every figure quoted for CagriSema comes from a clinical trial rather than an approved label
17,18 In a post-hoc analysis of the SUSTAIN-6 study, the additional risk factors of speed of hemoglobin A1c reduction with treatment, poor baseline glycemic control and insulin use at the initiation of GLP-1/GIP agonist treatment were reported ( Table 2 )
Glycemic Control SURPASS-2 showed tirzepatide 15 mg reduced HbA1c by 2.46 percentage points at 40 weeks versus 1.86 points for semaglutide 1 mg [1]
Protein is one of the strongest dietary triggers